Results 271 to 280 of about 180,771 (310)

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis

Transplant Infectious Disease, EarlyView.
This single‐center retrospective cohort study on 300 allogeneic hematopoietic stem cell transplant recipients from January 2017 to May 2020, in which posaconazole modified release was the most common primary antifungal prophylaxis, demonstrated a breakthrough invasive fungal disease (bIFD) rate of 9%, with associated significant all‐cause mortality at ...
Shio Yen Tio, Chin Fen Neoh, David Ritchie, Lynette Chee, David C. M. Kong, Leon J. Worth, Michelle K. Yong, Monica A. Slavin   +7 more
wiley   +1 more source

The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma. [PDF]

Ann Hematol
Koca O, Ozyurt B, Umar A, Ozmen D, Elverdi T, Salihoglu A, Ar MC, Baslar Z, Eskazan AE.   +8 more
europepmc   +1 more source

Respiratory Syncytial Virus Exceeded SARS‐CoV‐2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023–2024 Respiratory Virus Season

Transplant Infectious Disease, EarlyView.
During the 2023‐2024 respiratory viral season, respiratory syncytial virus infection was associated with worse outcomes compared to infections caused by SARS‐CoV‐2 and influenza virus in patients with hematologic malignancies ABSTRACT Background Respiratory viral infections (RVIs) significantly impact patients with hematologic malignancies (HMs ...
Tali Shafat, Amy Spallone, Fareed Khawaja, Ying Jiang, Jennifer Jackson, Lior Nesher, Roy F. Chemaly   +6 more
wiley   +1 more source

Preemptive Rituximab for Epstein–Barr Virus Reactivation after Hematopoietic Cell Transplantation: Necessary for All?

Transplant Infectious Disease, EarlyView.
A sudden increase in EBV DNAemia appears to be a better predictor of PTLD and EBV end‐organ disease than persistent and stable levels of EBV DNAemia. Most HCT recipients with EBV DNAemia did not require rituximab, and immunosuppression reduction was sufficient to control most episodes of EBV reactivation.
Anna Beatriz Coelho de Souza, Anderson João Simione, Ana Cláudia Ferrari dos Santos, Iago Colturato, Fernanda Rodrigues Barbieri, Juliana Ribeiro do Prado Moreno, Lilian Perílio Zanetti, Leila Cibele Serra de Oliveira, Erika Rodrigues Pontes Delattre, Juliana Silva Santos, Mair Pedro de Souza, Vergílio A. R. Colturato, Clarisse M. Machado   +12 more
wiley   +1 more source

Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study. [PDF]

Ann Hematol
Zheng W, Peng B, Chen H, Wang S, Guan L, Gao X.   +5 more
europepmc   +1 more source

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey, Paul R. Hess, Joanne L. Intile   +2 more
wiley   +1 more source

Evaluating the Use of Vincristine as a Substitute in Hodgkin Lymphoma Treatment. [PDF]

Cureus
Atmeh M, Al-Saudi MS, El-Ali TM, Rawshdeh A, Daheerat AN, AlNsour AAH, Sarhan Z, Alsharawneh A, Alghafri O, Alzghoul HM, Matalqa AW, Sarhan D, Dalaeen R, Al Husni AR, Atmeh M.   +14 more
europepmc   +1 more source

Artificial Intelligence in Veterinary Clinical Pathology—An Introduction and Review

Veterinary Clinical Pathology, EarlyView.
ABSTRACT Artificial intelligence (AI), particularly through machine learning and deep learning, presents opportunities for the enhancement of the workflow of the veterinary clinical pathologist. This review introduces basic concepts in AI in a nontechnical manner and explores the qualification and integration of AI in veterinary clinical pathology. The
Samuel V. Neal, Daniel G. Rudmann, Kara N. Corps   +2 more
wiley   +1 more source